Dual Mu/Delta Opioid Agonist (Protagonist Therapeutics)

N/A

Report date: 2025/01/26 16:22:16

Base Information

Drug NameDual Mu/Delta Opioid Agonist (Protagonist Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of Actionδ-opioid receptor agonistsMu opioid receptor agonists
TargetsMu opioid receptorδ-opioid receptor
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProtagonist Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesProtagonist Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsIrritable Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A